GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Navidea Biopharmaceuticals Inc (FRA:NO1A) » Definitions » Pre-Tax Income

Navidea Biopharmaceuticals (FRA:NO1A) Pre-Tax Income : €-8.07 Mil (TTM As of Sep. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Navidea Biopharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Navidea Biopharmaceuticals's pretax income for the three months ended in Sep. 2023 was €-2.11 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was €-8.07 Mil. Navidea Biopharmaceuticals's pretax margin was %.

During the past 13 years, Navidea Biopharmaceuticals's highest Pretax Margin was -402.07%. The lowest was -860600.00%. And the median was -7007.98%.


Navidea Biopharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Navidea Biopharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navidea Biopharmaceuticals Pre-Tax Income Chart

Navidea Biopharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.21 -9.85 -8.81 -10.37 -14.33

Navidea Biopharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.77 -3.29 -1.38 -1.29 -2.11

Competitive Comparison of Navidea Biopharmaceuticals's Pre-Tax Income

For the Biotechnology subindustry, Navidea Biopharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navidea Biopharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Navidea Biopharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Navidea Biopharmaceuticals's Pre-Tax Income falls into.



Navidea Biopharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Navidea Biopharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-13.264+-0.026+-1.037+0+-1.7763568394003E-15
=-14.33

Navidea Biopharmaceuticals's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.997+-0.02+-0.097+0+0.0010000000000003
=-2.11

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navidea Biopharmaceuticals  (FRA:NO1A) Pre-Tax Income Explanation

Navidea Biopharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-2.113/0
=%

During the past 13 years, Navidea Biopharmaceuticals's highest Pretax Margin was -402.07%. The lowest was -860600.00%. And the median was -7007.98%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navidea Biopharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Navidea Biopharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Navidea Biopharmaceuticals (FRA:NO1A) Business Description

Traded in Other Exchanges
Address
4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Navidea Biopharmaceuticals (FRA:NO1A) Headlines

No Headlines